• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种具有化生成分的基底样乳腺癌小鼠模型。

A mouse model of basal-like breast carcinoma with metaplastic elements.

作者信息

McCarthy A, Savage K, Gabriel A, Naceur C, Reis-Filho J S, Ashworth A

机构信息

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, UK.

出版信息

J Pathol. 2007 Mar;211(4):389-98. doi: 10.1002/path.2124.

DOI:10.1002/path.2124
PMID:17212342
Abstract

Breast cancers arising in carriers of germline BRCA1 mutations frequently have a basal-like phenotype. Basal-like cancers are characterized by high histological grade, central necrotic areas, foci with metaplastic differentiation, lack of hormone receptor and HER2 (ErbB2) expression, and consistent positivity for basal markers, including CK5/6, CK14, and EGFR. We have used germline manipulation to generate a conditional mouse model of Brca1 deficiency. Transgenic expression of Cre recombinase in the mammary gland of these mice results in deletion of exons encoding the C-terminus of Brca1 and leads to tumour formation when combined with heterozygosity for a p53 mutation. Histologically, these mammary gland tumours were characterized by high histological grade, central necrotic areas, and presence of homologous metaplastic elements. These metaplastic elements consisted of neoplastic spindle cells or squamous cell differentiation in the form of keratin pearls or individual cell keratinization. Immunohistochemical analysis revealed expression of basal-like markers in all cases. The tumour phenotype generated in our mouse model was compared with published data on human basal-like breast carcinomas and also with metaplastic breast cancers with a basal-like phenotype; the comparison showed that we have generated a mouse model of basal-like breast cancer, which should prove useful in testing new and targeted treatments for this type of breast cancer.

摘要

携带种系BRCA1突变的个体所患乳腺癌通常具有基底样表型。基底样癌的特征为组织学分级高、中央坏死区域、伴有化生分化的病灶、缺乏激素受体和HER2(ErbB2)表达,以及基底标志物(包括CK5/6、CK14和EGFR)持续呈阳性。我们利用种系操作构建了Brca1缺陷的条件性小鼠模型。在这些小鼠的乳腺中,Cre重组酶的转基因表达导致编码Brca1 C末端的外显子缺失,当与p53突变的杂合性相结合时会导致肿瘤形成。组织学上,这些乳腺肿瘤的特征为组织学分级高、中央坏死区域以及存在同源化生成分。这些化生成分由肿瘤性梭形细胞或以角化珠或单个细胞角化形式存在的鳞状细胞分化组成。免疫组织化学分析显示所有病例中均有基底样标志物表达。我们将在小鼠模型中产生的肿瘤表型与已发表的关于人类基底样乳腺癌的数据以及具有基底样表型的化生性乳腺癌的数据进行了比较;比较结果表明,我们构建了一个基底样乳腺癌的小鼠模型,这将证明对测试针对这类乳腺癌的新型靶向治疗方法有用。

相似文献

1
A mouse model of basal-like breast carcinoma with metaplastic elements.一种具有化生成分的基底样乳腺癌小鼠模型。
J Pathol. 2007 Mar;211(4):389-98. doi: 10.1002/path.2124.
2
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.BRCA1 缺失导致乳腺上皮细胞中表皮生长因子受体表达增加,表皮生长因子受体抑制可预防 BRCA1 突变小鼠中雌激素受体阴性癌症。
Breast Cancer Res. 2011 Mar 11;13(2):R30. doi: 10.1186/bcr2850.
3
Reproductive history determines Erbb2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model.生殖史决定了小鼠乳腺癌模型中的 Erbb2 基因座扩增、WNT 信号通路和肿瘤表型。
Dis Model Mech. 2021 May 1;14(5). doi: 10.1242/dmm.048736. Epub 2021 May 18.
4
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.小鼠中BRCA1和p53的体细胞缺失会诱发具有人类BRCA1突变基底样乳腺癌特征的乳腺肿瘤。
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12111-6. doi: 10.1073/pnas.0702969104. Epub 2007 Jul 11.
5
Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.p53的体细胞突变会导致雌激素受体α阳性和阴性的小鼠乳腺肿瘤,且转移频率很高。
Cancer Res. 2004 May 15;64(10):3525-32. doi: 10.1158/0008-5472.CAN-03-3524.
6
Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.Atm杂合性与Brca1缺失协同作用,增加乳腺癌的严重程度并减少导管分支。
Cancer Res. 2005 Oct 1;65(19):8736-46. doi: 10.1158/0008-5472.CAN-05-1598.
7
A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer.一种具有组织特异性 p53 和 Brca1 缺失的小鼠模型可导致具有与人类基底样乳腺癌类似基因组和转录组特征的乳腺肿瘤。
Breast Cancer Res Treat. 2019 Feb;174(1):143-155. doi: 10.1007/s10549-018-5061-y. Epub 2018 Nov 27.
8
Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.小鼠乳腺上皮细胞中靶向性Pten缺失加p53-R270H突变可诱导侵袭性的claudin低表达型和基底样乳腺癌。
Breast Cancer Res. 2016 Jan 19;18(1):9. doi: 10.1186/s13058-015-0668-y.
9
Metaplastic breast carcinomas and their relationship with basal-like phenotype.化生性乳腺癌及其与基底样表型的关系。
Turk Patoloji Derg. 2012;28(2):134-41. doi: 10.5146/tjpath.2012.01112.
10
The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.转录因子ATF3在小鼠乳腺肿瘤发生过程中发挥癌基因的作用。
BMC Cancer. 2008 Sep 22;8:268. doi: 10.1186/1471-2407-8-268.

引用本文的文献

1
Brca1 haploinsufficiency promotes early tumor onset and epigenetic alterations in a mouse model of hereditary breast cancer.在遗传性乳腺癌小鼠模型中,Brca1单倍体不足促进早期肿瘤发生和表观遗传改变。
Nat Genet. 2024 Dec;56(12):2763-2775. doi: 10.1038/s41588-024-01958-6. Epub 2024 Nov 11.
2
BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality.BRCA1和BRCA2:从癌症易感性到合成致死性
Genes Dev. 2025 Jan 7;39(1-2):86-108. doi: 10.1101/gad.352083.124.
3
Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer.
抑制 LSD1 恢复 TFPI2 可抑制乳腺癌的肿瘤进展并增强抗肿瘤免疫。
Cancer Lett. 2024 Sep 28;600:217182. doi: 10.1016/j.canlet.2024.217182. Epub 2024 Aug 21.
4
Conditional in vivo deletion of LYN kinase has little effect on a BRCA1 loss-of-function-associated mammary tumour model.条件性体内敲除 LYN 激酶对 BRCA1 功能丧失相关的乳腺肿瘤模型几乎没有影响。
Dis Model Mech. 2024 Jan 1;17(1). doi: 10.1242/dmm.050211. Epub 2024 Jan 25.
5
Brca1 Mouse Models: Functional Insights and Therapeutic Opportunities.BRCA1 小鼠模型:功能见解与治疗机遇。
J Mol Biol. 2024 Jan 1;436(1):168372. doi: 10.1016/j.jmb.2023.168372. Epub 2023 Nov 17.
6
Immature natural killer cells promote progression of triple-negative breast cancer.未成熟自然杀伤细胞促进三阴性乳腺癌进展。
Sci Transl Med. 2023 Mar 8;15(686):eabl4414. doi: 10.1126/scitranslmed.abl4414.
7
Lineage plasticity enables low-ER luminal tumors to evolve and gain basal-like traits.谱系可塑性使低内质网腔肿瘤能够进化并获得基底样特征。
Breast Cancer Res. 2023 Mar 1;25(1):23. doi: 10.1186/s13058-023-01621-8.
8
Genetically engineered mouse models for hereditary cancer syndromes.遗传性癌症综合征的基因工程小鼠模型。
Cancer Sci. 2023 May;114(5):1800-1815. doi: 10.1111/cas.15737. Epub 2023 Feb 14.
9
BRCA1 and TP53 codeficiency causes a PARP inhibitor-sensitive erythroproliferative neoplasm.BRCA1 和 TP53 共缺失导致 PARP 抑制剂敏感的红细胞增生性肿瘤。
JCI Insight. 2022 Dec 22;7(24):e158257. doi: 10.1172/jci.insight.158257.
10
Loss of the BRCA1-PALB2 interaction accelerates p53-associated tumor development in mice.BRCA1与PALB2相互作用的丧失会加速小鼠中与p53相关的肿瘤发展。
Genes Dis. 2020 Sep 5;9(3):807-813. doi: 10.1016/j.gendis.2020.08.012. eCollection 2022 May.